标题/作者	年份
Significant applications of virtual reality for COVID-19 pandemic RP Singh, M Javaid, R Kataria, M Tyagi, A Haleem, R Suman Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (4), 661-664	2020
Neurological and neuropsychiatric impacts of COVID-19 pandemic D Roy, R Ghosh, S Dubey, MJ Dubey, J Benito-Leon, BK Ray Canadian Journal of Neurological Sciences 48 (1), 9-24	2021
Effects of COVID‐19 on Parkinson's disease clinical features: a community‐based case‐control study R Cilia, S Bonvegna, G Straccia, NG Andreasi, AE Elia, LM Romito, ... Movement Disorders 35 (8), 1287-1292	2020
COVID‐19 in Parkinson’s disease patients living in Lombardy, Italy A Fasano, E Cereda, M Barichella, E Cassani, V Ferri, AL Zecchinelli, ... Movement Disorders 35 (7), 1089-1093	2020
COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? L Ferini-Strambi, M Salsone Journal of neurology 268 (2), 409-419	2021
COVID-19-associated neurological disorders: the potential route of CNS invasion and blood-brain barrier relevance A Achar, C Ghosh Cells 9 (11), 2360	2020
COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside D Sulzer, A Antonini, V Leta, A Nordvig, RJ Smeyne, JE Goldman, ... npj Parkinson's Disease 6 (1), 18	2020
Поражение нервной системы при СOVID-19 ВВ Белопасов, Я Яссин, ЕМ Самойлова, ВП Баклаушев Клиническая практика 11 (2), 60-80	2020
COVID‑19 related stress exacerbates common physical and mental pathologies and affects treatment K Tsamakis, AS Triantafyllis, D Tsiptsios, E Spartalis, C Mueller, ... Experimental and therapeutic medicine 20 (1), 159-162	2020
Management of advanced therapies in Parkinson's disease patients in times of humanitarian crisis: the COVID‐19 experience A Fasano, A Antonini, R Katzenschlager, P Krack, P Odin, AH Evans, ... Movement disorders clinical practice 7 (4), 361-372	2020
Neurological complications in patients with SARS-CoV-2 infection: a systematic review RP Munhoz, JL Pedroso, FA Nascimento, SM Almeida, OGP Barsottini, ... Arquivos de Neuro-Psiquiatria 78, 290-300	2020
Parkinson's disease and COVID‐19: perceptions and implications in patients and caregivers S Prasad, VV Holla, K Neeraja, BK Surisetti, N Kamble, R Yadav, PK Pal Movement Disorders 35 (6), 912	2020
COVID-19: an early review of its global impact and considerations for Parkinson’s disease patient care R Bhidayasiri, S Virameteekul, JM Kim, PK Pal, SJ Chung Journal of movement disorders 13 (2), 105	2020
Parkinson’s disease and the COVID-19 pandemic C Fearon, A Fasano Journal of Parkinson's Disease 11 (2), 431-444	2021
Global survey on telemedicine utilization for movement disorders during the COVID‐19 pandemic A Hassan, Z Mari, EM Gatto, A Cardozo, J Youn, N Okubadejo, JA Bajwa, ... Movement Disorders 35 (10), 1701-1711	2020
Mitochondria: in the cross fire of SARS-CoV-2 and immunity J Burtscher, G Cappellano, A Omori, T Koshiba, GP Millet IScience 23 (10)	2020
Alzheimer’s and Parkinson’s diseases predict different COVID-19 outcomes: a UK Biobank study Y Yu, M Travaglio, R Popovic, NS Leal, LM Martins Geriatrics 6 (1), 10	2021
Impact of coronavirus disease 2019 pandemic on Parkinson's disease: a cross‐sectional survey of 568 Spanish patients D Santos‐García, M Oreiro, P Pérez, G Fanjul, JM Paz Gonzalez, ... Movement Disorders 35 (10), 1712-1716	2020
Recommendations for deep brain stimulation device management during a pandemic S Miocinovic, JL Ostrem, MS Okun, KL Bullinger, P Riva-Posse, RE Gross, ... Journal of Parkinson's disease 10 (3), 903-910	2020
Physical activity changes and correlate effects in patients with Parkinson's disease during COVID‐19 lockdown T Schirinzi, G Di Lazzaro, C Salimei, R Cerroni, C Liguori, S Scalise, ... Movement disorders clinical practice 7 (7), 797-802	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。